FIRST LIGHT ASSET MANAGEMENT, LLC Holdings

FIRST LIGHT ASSET MANAGEMENT, LLC is an investment fund managing more than 988.11M US dollars. The largest holdings include Prothena Corporation, Model N and AtriCure. In Q3 2022 the fund bought assets of total value of 84.83M US dollars and sold assets of total value of 51.13M US dollars.

$988.11M

portfolio value

+14.72%

quarter

-33.12%

1 year

+33.78%

3 years

+142.14%

5 years

FIRST LIGHT ASSET MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	-11977000	20743000
Q2 2016	30467000	19093000
Q3 2016	25086000	8306000
Q4 2016	24934000	10559000
Q1 2017	50161000	13286000
Q2 2017	33431000	1029000
Q3 2017	53752000	42721000
Q4 2017	57846000	6493000
Q1 2018	96064000	5276000
Q2 2018	166996000	6360000
Q3 2018	30390000	50428000
Q4 2018	90208000	88028000
Q1 2019	165683000	15248000
Q2 2019	62351000	137128000
Q3 2019	118261000	101433000
Q4 2019	85285000	38956000
Q1 2020	102468000	296913000
Q2 2020	302751000	16015000
Q3 2020	155654000	43111000
Q4 2020	479180000	38377000
Q1 2021	417248000	174358000
Q2 2021	187187000	29028000
Q3 2021	69001000	213423000
Q4 2021	123042000	235416000
Q1 2022	6952000	198409000
Q2 2022	-119174000	135164000
Q3 2022	84829000	51134000

FIRST LIGHT ASSET MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Prothena Corporation plc Portfolio share: 9.44% Portfolio value: 93.29M Avg. open price: $26.94 Current price: $60.39 P/L: +124.20% Sold -20.61% shares Q3 2022	share	9.44%	93.29M	$26.94	$60.39	+124.20%	Sold -20.61% shares Q3 2022
Software—Application Model N, Inc. Portfolio share: 9.04% Portfolio value: 89.27M Avg. open price: $24.67 Current price: $38.51 P/L: +56.10% Sold -5.29% shares Q3 2022	share	9.04%	89.27M	$24.67	$38.51	+56.10%	Sold -5.29% shares Q3 2022
Medical Instruments & Supplies AtriCure, Inc. Portfolio share: 5.91% Portfolio value: 58.44M Avg. open price: $46.93 Current price: $43.65 P/L: -6.99% Bought +1.02% shares Q3 2022	share	5.91%	58.44M	$46.93	$43.65	-6.99%	Bought +1.02% shares Q3 2022
Medical Devices SeaSpine Holdings Corporation Portfolio share: 4.06% Portfolio value: 40.14M Avg. open price: $13.03 Current price: $7.67 P/L: -41.14% Bought +0.53% shares Q3 2022	share	4.06%	40.14M	$13.03	$7.67	-41.14%	Bought +0.53% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 3.79% Portfolio value: 37.40M Avg. open price: $108.74 Current price: $226.95 P/L: +108.71% Bought +32.21% shares Q3 2022	share	3.79%	37.40M	$108.74	$226.95	+108.71%	Bought +32.21% shares Q3 2022
Biotechnology Halozyme Therapeutics, Inc. Portfolio share: 3.73% Portfolio value: 36.86M Avg. open price: $21.79 Current price: $55.94 P/L: +156.68% Sold -0.96% shares Q3 2022	share	3.73%	36.86M	$21.79	$55.94	+156.68%	Sold -0.96% shares Q3 2022
Medical Devices SI-BONE, Inc. Portfolio share: 3.58% Portfolio value: 35.40M Avg. open price: $22.27 Current price: $12.08 P/L: -45.76% Bought +1.08% shares Q3 2022	share	3.58%	35.40M	$22.27	$12.08	-45.76%	Bought +1.08% shares Q3 2022
Medical Devices Cutera, Inc. Portfolio share: 3.52% Portfolio value: 34.80M Avg. open price: $39.26 Current price: $51.65 P/L: +31.56% Sold -1.12% shares Q3 2022	share	3.52%	34.80M	$39.26	$51.65	+31.56%	Sold -1.12% shares Q3 2022
Medical Devices AxoGen, Inc. Portfolio share: 3.51% Portfolio value: 34.70M Avg. open price: $11.9 Current price: $10.93 P/L: -8.18% Sold -3.75% shares Q3 2022	share	3.51%	34.70M	$11.9	$10.93	-8.18%	Sold -3.75% shares Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 3.47% Portfolio value: 34.33M Avg. open price: $64.01 Current price: $75.78 P/L: +18.39% Sold -17.30% shares Q3 2022	share	3.47%	34.33M	$64.01	$75.78	+18.39%	Sold -17.30% shares Q3 2022
Health Information Services Omnicell, Inc. Portfolio share: 3.07% Portfolio value: 30.38M Avg. open price: $58.07 Current price: $49.45 P/L: -14.84% Bought +0.60% shares Q3 2022	share	3.07%	30.38M	$58.07	$49.45	-14.84%	Bought +0.60% shares Q3 2022
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 2.68% Portfolio value: 26.51M Avg. open price: N/A Current price: $39.62 P/L: N/A N/A Q3 2022	share	2.68%	26.51M	N/A	$39.62	N/A	N/A Q3 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 2.68% Portfolio value: 26.44M Avg. open price: $23.38 Current price: $18.32 P/L: -21.64% Bought +8.55% shares Q3 2022	share	2.68%	26.44M	$23.38	$18.32	-21.64%	Bought +8.55% shares Q3 2022
Medical Devices Alphatec Holdings, Inc. Portfolio share: 2.63% Portfolio value: 25.99M Avg. open price: $13.76 Current price: $9.75 P/L: -29.15% Bought +1.70% shares Q3 2022	share	2.63%	25.99M	$13.76	$9.75	-29.15%	Bought +1.70% shares Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 2.55% Portfolio value: 25.15M Avg. open price: $8.09 Current price: $10.02 P/L: +23.86% Sold -1.09% shares Q3 2022	share	2.55%	25.15M	$8.09	$10.02	+23.86%	Sold -1.09% shares Q3 2022
Diagnostics & Research NeoGenomics, Inc. Portfolio share: 2.37% Portfolio value: 23.42M Avg. open price: $15.13 Current price: $11.8 P/L: -22.00% Bought +0.17% shares Q3 2022	share	2.37%	23.42M	$15.13	$11.8	-22.00%	Bought +0.17% shares Q3 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 2.35% Portfolio value: 23.23M Avg. open price: $87.18 Current price: $42.44 P/L: -51.32% Bought +3.86% shares Q3 2022	share	2.35%	23.23M	$87.18	$42.44	-51.32%	Bought +3.86% shares Q3 2022
Biotechnology Keros Therapeutics, Inc. Portfolio share: 2.28% Portfolio value: 22.50M Avg. open price: $43.22 Current price: $50 P/L: +15.69% Sold -0.02% shares Q3 2022	share	2.28%	22.50M	$43.22	$50	+15.69%	Sold -0.02% shares Q3 2022
Medical Devices Axonics, Inc. Portfolio share: 2.26% Portfolio value: 22.31M Avg. open price: $58.18 Current price: $67.47 P/L: +15.96% Bought +0.89% shares Q3 2022	share	2.26%	22.31M	$58.18	$67.47	+15.96%	Bought +0.89% shares Q3 2022
Medical Devices Paragon 28, Inc. Portfolio share: 2.23% Portfolio value: 22.06M Avg. open price: $17.65 Current price: $19.38 P/L: +9.83% Bought +0.04% shares Q3 2022	share	2.23%	22.06M	$17.65	$19.38	+9.83%	Bought +0.04% shares Q3 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 2.04% Portfolio value: 20.16M Avg. open price: $7.63 Current price: $17 P/L: +122.72% Bought +25.44% shares Q3 2022	share	2.04%	20.16M	$7.63	$17	+122.72%	Bought +25.44% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 1.90% Portfolio value: 18.79M Avg. open price: $74.92 Current price: $39.83 P/L: -46.83% Bought +0.29% shares Q3 2022	share	1.90%	18.79M	$74.92	$39.83	-46.83%	Bought +0.29% shares Q3 2022
Biotechnology Bicycle Therapeutics plc Portfolio share: 1.66% Portfolio value: 16.39M Avg. open price: $41.55 Current price: $32.41 P/L: -22.00% Bought +0.06% shares Q3 2022	share	1.66%	16.39M	$41.55	$32.41	-22.00%	Bought +0.06% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 1.65% Portfolio value: 16.29M Avg. open price: $32.78 Current price: $19.89 P/L: -39.33% Sold -0.76% shares Q3 2022	share	1.65%	16.29M	$32.78	$19.89	-39.33%	Sold -0.76% shares Q3 2022
Medical Devices OrthoPediatrics Corp. Portfolio share: 1.44% Portfolio value: 14.24M Avg. open price: $47.44 Current price: $39.38 P/L: -16.99% Sold -1.91% shares Q3 2022	share	1.44%	14.24M	$47.44	$39.38	-16.99%	Sold -1.91% shares Q3 2022
Medical Instruments & Supplies KORU Medical Systems, Inc. Portfolio share: 1.42% Portfolio value: 13.99M Avg. open price: $3.79 Current price: $3.27 P/L: -13.68% Bought +2.80% shares Q3 2022	share	1.42%	13.99M	$3.79	$3.27	-13.68%	Bought +2.80% shares Q3 2022
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 1.26% Portfolio value: 12.49M Avg. open price: $16.25 Current price: $5.6 P/L: -65.55% Sold -15.88% shares Q3 2022	share	1.26%	12.49M	$16.25	$5.6	-65.55%	Sold -15.88% shares Q3 2022
Health Information Services Health Catalyst, Inc. Portfolio share: 1.13% Portfolio value: 11.15M Avg. open price: $32.87 Current price: $10.84 P/L: -67.03% Bought +1.29% shares Q3 2022	share	1.13%	11.15M	$32.87	$10.84	-67.03%	Bought +1.29% shares Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 1.11% Portfolio value: 10.98M Avg. open price: $19.98 Current price: $18.33 P/L: -8.26% Bought +88.30% shares Q3 2022	share	1.11%	10.98M	$19.98	$18.33	-8.26%	Bought +88.30% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 1.06% Portfolio value: 10.45M Avg. open price: $82.45 Current price: $103.53 P/L: +25.56% Bought +17.66% shares Q3 2022	share	1.06%	10.45M	$82.45	$103.53	+25.56%	Bought +17.66% shares Q3 2022
Medical Devices Bioventus Inc. Portfolio share: 0.99% Portfolio value: 9.79M Avg. open price: $13.36 Current price: $2.25 P/L: -83.16% Bought +3.74% shares Q3 2022	share	0.99%	9.79M	$13.36	$2.25	-83.16%	Bought +3.74% shares Q3 2022
Diagnostics & Research CareDx, Inc Portfolio share: 0.95% Portfolio value: 9.35M Avg. open price: $32.48 Current price: $12.53 P/L: -61.42% Sold -29.21% shares Q3 2022	share	0.95%	9.35M	$32.48	$12.53	-61.42%	Sold -29.21% shares Q3 2022
Specialty Business Services Performant Financial Corporation Portfolio share: 0.94% Portfolio value: 9.28M Avg. open price: $3.55 Current price: $2.37 P/L: -33.31% Bought +0.01% shares Q3 2022	share	0.94%	9.28M	$3.55	$2.37	-33.31%	Bought +0.01% shares Q3 2022
Medical Devices MaxCyte, Inc. Portfolio share: 0.90% Portfolio value: 8.85M Avg. open price: $10.92 Current price: $5.43 P/L: -50.30% Bought +3.26% shares Q3 2022	share	0.90%	8.85M	$10.92	$5.43	-50.30%	Bought +3.26% shares Q3 2022
Drug Manufacturers—General Pfizer Inc. Portfolio share: 0.65% Portfolio value: 6.43M Avg. open price: $43 Current price: $50.73 P/L: +17.99% Bought +0.54% shares Q3 2022	share	0.65%	6.43M	$43	$50.73	+17.99%	Bought +0.54% shares Q3 2022
Diagnostics & Research Akumin Inc. Portfolio share: 0.65% Portfolio value: 6.43M Avg. open price: $3.5 Current price: $1.08 P/L: -69.11% Bought +1.45% shares Q2 2022	share	0.65%	6.43M	$3.5	$1.08	-69.11%	Bought +1.45% shares Q2 2022
Medical Devices TransMedics Group, Inc. Portfolio share: 0.65% Portfolio value: 6.41M Avg. open price: N/A Current price: $61.9 P/L: N/A N/A Q3 2022	share	0.65%	6.41M	N/A	$61.9	N/A	N/A Q3 2022
Direxion Daily S&P Biotech Bull 3X Shares Portfolio share: 0.61% Portfolio value: 6.01M Avg. open price: N/A Current price: $7.27 P/L: N/A N/A Q3 2022	share	0.61%	6.01M	N/A	$7.27	N/A	N/A Q3 2022
Biotechnology Abcam plc Portfolio share: 0.58% Portfolio value: 5.75M Avg. open price: $14.69 Current price: $16.13 P/L: +9.83% Bought +73.68% shares Q3 2022	share	0.58%	5.75M	$14.69	$16.13	+9.83%	Bought +73.68% shares Q3 2022
Health Information Services OptimizeRx Corporation Portfolio share: 0.55% Portfolio value: 5.39M Avg. open price: $35.52 Current price: $19.21 P/L: -45.92% Bought +0.91% shares Q3 2022	share	0.55%	5.39M	$35.52	$19.21	-45.92%	Bought +0.91% shares Q3 2022
Biotechnology Genmab A/S Portfolio share: 0.53% Portfolio value: 5.19M Avg. open price: $39.32 Current price: $46.04 P/L: +17.10% Bought +0.52% shares Q3 2022	share	0.53%	5.19M	$39.32	$46.04	+17.10%	Bought +0.52% shares Q3 2022
Diagnostics & Research Castle Biosciences, Inc. Portfolio share: 0.43% Portfolio value: 4.25M Avg. open price: N/A Current price: $24.41 P/L: N/A N/A Q3 2022	share	0.43%	4.25M	N/A	$24.41	N/A	N/A Q3 2022
Medical Devices Inari Medical, Inc. Portfolio share: 0.33% Portfolio value: 3.29M Avg. open price: $81.27 Current price: $71.11 P/L: -12.50% Bought +0.63% shares Q3 2022	share	0.33%	3.29M	$81.27	$71.11	-12.50%	Bought +0.63% shares Q3 2022
Biotechnology Miromatrix Medical Inc. Portfolio share: 0.23% Portfolio value: 2.26M Avg. open price: $5.27 Current price: $4.05 P/L: -23.18% Bought +0.72% shares Q2 2022	share	0.23%	2.26M	$5.27	$4.05	-23.18%	Bought +0.72% shares Q2 2022
Health Information Services Simulations Plus, Inc. Portfolio share: 0.18% Portfolio value: 1.75M Avg. open price: $21.25 Current price: $40.07 P/L: +88.60% Sold -52.54% shares Q3 2022	share	0.18%	1.75M	$21.25	$40.07	+88.60%	Sold -52.54% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 0.06% Portfolio value: 565K Avg. open price: N/A Current price: $522.34 P/L: N/A Bought +56.48% shares Q4 2020	share	0.06%	565K	N/A	$522.34	N/A	Bought +56.48% shares Q4 2020
Healthcare Plans CIGNA CORPORATION Portfolio share: 0.05% Portfolio value: 539K Avg. open price: $205.52 Current price: $327.39 P/L: +59.30% Bought +24.55% shares Q1 2021	share	0.05%	539K	$205.52	$327.39	+59.30%	Bought +24.55% shares Q1 2021
Healthcare Plans CVS Health Corporation Portfolio share: 0.05% Portfolio value: 526K Avg. open price: $66.61 Current price: $102.01 P/L: +53.14% Bought +31.97% shares Q1 2021	share	0.05%	526K	$66.61	$102.01	+53.14%	Bought +31.97% shares Q1 2021
Healthcare Plans Humana Inc. Portfolio share: 0.05% Portfolio value: 518K Avg. open price: N/A Current price: $547.42 P/L: N/A N/A Q2 2021	share	0.05%	518K	N/A	$547.42	N/A	N/A Q2 2021
Drug Manufacturers—General Bristol-Myers Squibb Company Portfolio share: 0.05% Portfolio value: 516K Avg. open price: N/A Current price: $80.7 P/L: N/A N/A Q1 2021	share	0.05%	516K	N/A	$80.7	N/A	N/A Q1 2021
Biotechnology United Therapeutics Corporation Portfolio share: 0.05% Portfolio value: 516K Avg. open price: N/A Current price: $273.72 P/L: N/A N/A Q1 2021	share	0.05%	516K	N/A	$273.72	N/A	N/A Q1 2021
Drug Manufacturers—General AbbVie Inc. Portfolio share: 0.05% Portfolio value: 502K Avg. open price: $69.88 Current price: $163.96 P/L: +134.62% Sold -37.47% shares Q2 2021	share	0.05%	502K	$69.88	$163.96	+134.62%	Sold -37.47% shares Q2 2021
Medical Distribution McKesson Corporation Portfolio share: 0.05% Portfolio value: 457K Avg. open price: N/A Current price: $382.44 P/L: N/A N/A Q1 2021	share	0.05%	457K	N/A	$382.44	N/A	N/A Q1 2021
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 0.04% Portfolio value: 421K Avg. open price: $241.55 Current price: $246.21 P/L: +1.93% Sold -2.48% shares Q2 2022	share	0.04%	421K	$241.55	$246.21	+1.93%	Sold -2.48% shares Q2 2022
Diagnostics & Research Waters Corporation Portfolio share: 0.04% Portfolio value: 414K Avg. open price: N/A Current price: $340.29 P/L: N/A N/A Q1 2021	share	0.04%	414K	N/A	$340.29	N/A	N/A Q1 2021
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 0.04% Portfolio value: 414K Avg. open price: $56.43 Current price: $87.98 P/L: +55.90% Bought +29.57% shares Q1 2021	share	0.04%	414K	$56.43	$87.98	+55.90%	Bought +29.57% shares Q1 2021
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 0.04% Portfolio value: 387K Avg. open price: $33.73 Current price: $33.51 P/L: -0.65% Bought +31.25% shares Q1 2021	share	0.04%	387K	$33.73	$33.51	-0.65%	Bought +31.25% shares Q1 2021
Medical Instruments & Supplies Hologic, Inc. Portfolio share: 0.04% Portfolio value: 377K Avg. open price: $72.83 Current price: $75.11 P/L: +3.13% Bought +75.00% shares Q1 2021	share	0.04%	377K	$72.83	$75.11	+3.13%	Bought +75.00% shares Q1 2021
Medical Devices Integer Holdings Corporation Portfolio share: 0.04% Portfolio value: 364K Avg. open price: N/A Current price: $72.27 P/L: N/A N/A Q1 2021	share	0.04%	364K	N/A	$72.27	N/A	N/A Q1 2021
Drug Manufacturers—General Johnson & Johnson Portfolio share: 0.04% Portfolio value: 353K Avg. open price: N/A Current price: $178.78 P/L: N/A Sold -1.01% shares Q1 2019	share	0.04%	353K	N/A	$178.78	N/A	Sold -1.01% shares Q1 2019
Drug Manufacturers—Specialty & Generic Perrigo Company plc Portfolio share: 0.04% Portfolio value: 350K Avg. open price: $43.69 Current price: $31.81 P/L: -27.19% Bought +86.22% shares Q1 2021	share	0.04%	350K	$43.69	$31.81	-27.19%	Bought +86.22% shares Q1 2021
Medical Devices NuVasive, Inc. Portfolio share: 0.03% Portfolio value: 344K Avg. open price: $56.33 Current price: $39.63 P/L: -29.65% Bought +50.15% shares Q1 2021	share	0.03%	344K	$56.33	$39.63	-29.65%	Bought +50.15% shares Q1 2021
Drug Manufacturers—Specialty & Generic Takeda Pharmaceutical Company Limited Portfolio share: 0.03% Portfolio value: 332K Avg. open price: $18.96 Current price: $14.56 P/L: -23.20% N/A Q2 2021	share	0.03%	332K	$18.96	$14.56	-23.20%	N/A Q2 2021
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 0.03% Portfolio value: 319K Avg. open price: $79.15 Current price: $51.3 P/L: -35.19% Bought +81.98% shares Q1 2021	share	0.03%	319K	$79.15	$51.3	-35.19%	Bought +81.98% shares Q1 2021
Medical Instruments & Supplies ICU Medical, Inc. Portfolio share: 0.03% Portfolio value: 307K Avg. open price: $214.49 Current price: $156.19 P/L: -27.18% Bought +95.87% shares Q1 2021	share	0.03%	307K	$214.49	$156.19	-27.18%	Bought +95.87% shares Q1 2021
Drug Manufacturers—General GSK plc Portfolio share: 0.03% Portfolio value: 296K Avg. open price: N/A Current price: $35.16 P/L: N/A N/A Q3 2022	share	0.03%	296K	N/A	$35.16	N/A	N/A Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 0.03% Portfolio value: 286K Avg. open price: N/A Current price: $22.35 P/L: N/A N/A Q1 2021	share	0.03%	286K	N/A	$22.35	N/A	N/A Q1 2021
Diagnostics & Research Syneos Health, Inc. Portfolio share: 0.03% Portfolio value: 270K Avg. open price: $68.13 Current price: $34.66 P/L: -49.13% Bought +28.35% shares Q1 2021	share	0.03%	270K	$68.13	$34.66	-49.13%	Bought +28.35% shares Q1 2021
Drug Manufacturers—General Sanofi Portfolio share: 0.03% Portfolio value: 253K Avg. open price: $31.37 Current price: $44.93 P/L: +43.21% Sold -1.04% shares Q1 2019	share	0.03%	253K	$31.37	$44.93	+43.21%	Sold -1.04% shares Q1 2019
Medical Devices Sonendo, Inc. Portfolio share: 0.02% Portfolio value: 239K Avg. open price: N/A Current price: $2.63 P/L: N/A N/A Q3 2022	share	0.02%	239K	N/A	$2.63	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Haleon plc Portfolio share: 0.01% Portfolio value: 77K Avg. open price: N/A Current price: $7.15 P/L: N/A N/A Q3 2022	share	0.01%	77K	N/A	$7.15	N/A	N/A Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $87.34 Current price: $76.01 P/L: -12.97% Sold -100.00% shares Q3 2022	share	0.00%	0	$87.34	$76.01	-12.97%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $35.16 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$35.16	N/A	Sold -100.00% shares Q3 2022
Biotechnology Codexis, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $15.62 Current price: $5.93 P/L: -62.04% Sold -100.00% shares Q3 2022	share	0.00%	0	$15.62	$5.93	-62.04%	Sold -100.00% shares Q3 2022
Medical Devices Sientra, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.37 Current price: $0.27 P/L: -96.28% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.37	$0.27	-96.28%	Sold -100.00% shares Q3 2022
Medical Care Facilities Universal Health Services, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $127.36 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$127.36	N/A	Sold -100.00% shares Q3 2022
Medical Care Facilities LHC Group, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $43.44 Current price: $162.06 P/L: +273.08% Sold -100.00% shares Q3 2022	share	0.00%	0	$43.44	$162.06	+273.08%	Sold -100.00% shares Q3 2022
iShares Russell 2000 Growth ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $224.66 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$224.66	N/A	Sold -100.00% shares Q3 2022

Showing TOP 78 FIRST LIGHT ASSET MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of FIRST LIGHT ASSET MANAGEMENT, LLC?

The biggest position of the FIRST LIGHT ASSET MANAGEMENT, LLC is Prothena Corporation plc (PRTA) with 9.44% portfolio share worth of 93.29M US dollars.

Top 5 FIRST LIGHT ASSET MANAGEMENT's holdings represent 32.24% of the portfolio:

Prothena Corporation plc (PRTA) – 9.44%
Model N, Inc. (MODN) – 9.04%
AtriCure, Inc. (ATRC) – 5.91%
SeaSpine Holdings Corporation (SPNE) – 4.06%
Karuna Therapeutics, Inc. (KRTX) – 3.79%

Who is the portfolio manager of FIRST LIGHT ASSET MANAGEMENT, LLC?

The portfolio manager of the FIRST LIGHT ASSET MANAGEMENT, LLC is .

What is the total asset value of the FIRST LIGHT ASSET MANAGEMENT, LLC portfolio?

FIRST LIGHT ASSET MANAGEMENT, LLC total asset value (portfolio value) is 988.11M US dollars.

Who is ?

is the portfolio manager of the FIRST LIGHT ASSET MANAGEMENT, LLC.

What is (FIRST LIGHT ASSET MANAGEMENT, LLC) fund performance?

FIRST LIGHT ASSET MANAGEMENT's quarterly performance is +14.72%, annualy -33.12%. In the past 3 years, the value of 's portfolio has increased by +34%. In the past 5 years, the value of the portfolio has increased by +142%.

What is the FIRST LIGHT ASSET MANAGEMENT, LLC CIK?

FIRST LIGHT ASSET MANAGEMENT's Central Index Key is 0001600004 .

FIRST LIGHT ASSET MANAGEMENT, LLC Holdings

FIRST LIGHT ASSET MANAGEMENT, LLC portfolio value:

FIRST LIGHT ASSET MANAGEMENT, LLC quarter portfolio value change:

FIRST LIGHT ASSET MANAGEMENT, LLC 1 year portfolio value change:

FIRST LIGHT ASSET MANAGEMENT, LLC 3 years portfolio value change:

FIRST LIGHT ASSET MANAGEMENT, LLC 5 years portfolio value change: